Showing CypComp Card for CC00190: Efavirenz (CypReact Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:17:58 UTC
Last Updated2019-10-01 21:37:29 UTC
CypComp IDCC00190
Compound Information
NameEfavirenz
Structure ImageXpoqhmrabvbwpr zdusscgksa n
InChIKeyXPOQHMRABVBWPR-ZDUSSCGKSA-N
PubChem ID64139
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
ReactantReactantReactantNon-ReactantReactantNon-ReactantNon-ReactantNon-ReactantReactant
References
  1. Ward BA, Gorski JC, Jones DR, Hall SD, Flockhart DA, Desta Z: The cytochrome P450 2B6 (CYP2B6) is the main catalyst of efavirenz primary and secondary metabolism: implication for HIV/AIDS therapy and utility of efavirenz as a substrate marker of CYP2B6 catalytic activity. J Pharmacol Exp Ther. 2003 Jul;306(1):287-300. doi: 10.1124/jpet.103.049601. Epub 2003 Apr 3. [PubMed:12676886 ]
  2. Ogburn ET, Jones DR, Masters AR, Xu C, Guo Y, Desta Z: Efavirenz primary and secondary metabolism in vitro and in vivo: identification of novel metabolic pathways and cytochrome P450 2A6 as the principal catalyst of efavirenz 7-hydroxylation. Drug Metab Dispos. 2010 Jul;38(7):1218-29. doi: 10.1124/dmd.109.031393. Epub 2010 Mar 24. [PubMed:20335270 ]
Download FileCC00190.sdf